Apimeds Pharmaceuticals US (APUS) Amortizatization of Intangibles (2024 - 2025)
Apimeds Pharmaceuticals US (APUS) posted Amortizatization of Intangibles of $243177.0 for Q4 2025, up 24317600.0% on a QoQ basis from $1.0 in Q3 2025, and up 288.35% year-over-year from $62618.0 in Q4 2024.
Apimeds Pharmaceuticals US (APUS) Amortizatization of Intangibles (2024 - 2025) Analysis & Trends
Apimeds Pharmaceuticals US's Amortizatization of Intangibles history runs 2 years deep, the most recent figure standing at $243177.0 for Q4 2025.
- Quarterly Amortizatization of Intangibles rose 288.35% year-over-year to $243177.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $283010.0 (up 140.41% YoY) and the FY2025 annual result came in at $283010.0, up 140.41% from the prior year.
- Amortizatization of Intangibles was $243177.0 for Q4 2025 at Apimeds Pharmaceuticals US, up from $1.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $243177.0 in Q4 2025 and bottomed at $1.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 1.30 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Apimeds Pharmaceuticals US | 62.67 Mn | 62.67 Mn | - | 243,177.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 243,177.00 |
| Dec 31, 2025 | 243,177.00 |
| Sep 30, 2025 | 1.00 |
| Sep 30, 2025 | 1.00 |
| Jun 30, 2025 | 13,056.00 |
| Jun 30, 2025 | 13,056.00 |
| Mar 31, 2025 | 26,776.00 |
| Mar 31, 2025 | 26,776.00 |
| Dec 31, 2024 | 62,618.00 |
| Dec 31, 2024 | 62,618.00 |
| Sep 30, 2024 | 22,530.00 |
| Sep 30, 2024 | 22,530.00 |
| Jun 30, 2024 | 13,619.00 |
| Jun 30, 2024 | 13,619.00 |
| Mar 31, 2024 | 18,952.00 |
| Mar 31, 2024 | 18,952.00 |